SEC 13F Intelligence

Tsfg, LLC / ABT

Tsfg, LLC’s Abbott Laboratories Position

Does Tsfg, LLC own Abbott Laboratories (ABT)? Yes113.3K shares worth $12M (+1.76% of its 13F portfolio) as of Q1 2026, down from 116.5K shares the prior filed quarter.

Position Value
$12M
Q1 2026
Shares
113.3K
% of Portfolio
+1.76%
Quarters Held
26
currently held

Position History ABT

Reported value by quarter
Q4 ’19: $4MQ4 ’19Q1 ’20: $4MQ2 ’20: $5MQ3 ’20: $8MQ4 ’20: $8MQ4 ’20Q1 ’21: $9MQ2 ’21: $9MQ3 ’21: $9MQ4 ’21: $12MQ4 ’21Q1 ’22: $10MQ2 ’22: $9MQ3 ’22: $9MQ4 ’22: $10MQ4 ’22Q1 ’23: $9MQ2 ’23: $10MQ3 ’23: $9MQ4 ’23: $11MQ4 ’23Q1 ’24: $10MQ2 ’24: $10MQ3 ’24: $11MQ4 ’24: $12MQ4 ’24Q1 ’25: $14MQ2 ’25: $15MQ3 ’25: $15MQ4 ’25: $15MQ4 ’25Q1 ’26: $12Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026113.3K$12M+1.76%
Q4 2025116.5K$15M+2.18%
Q3 2025114.0K$15M+2.43%
Q2 2025107.3K$15M+2.64%
Q1 2025103.8K$14M+2.82%
Q4 2024106.1K$12M+2.46%
Q3 202494.2K$11M+2.35%
Q2 202496.0K$10M+2.33%
Q1 202490.2K$10M+2.59%
Q4 202399.2K$11M+3.44%
Q3 202396.2K$9M+3.32%
Q2 202391.5K$10M+3.72%
Q1 202392.8K$9M+3.48%
Q4 202291.4K$10M+3.99%
Q3 202289.0K$9M+4.03%
Q2 202283.8K$9M+3.91%
Q1 202284.1K$10M+3.60%
Q4 202185.3K$12M+4.18%
Q3 202177.5K$9M+3.57%
Q2 202174.6K$9M+3.48%
Q1 202172.0K$9M+4.38%
Q4 202070.1K$8M+4.10%
Q3 202070.1K$8M+4.53%
Q2 202051.6K$5M+3.11%
Q1 202047.3K$4M+3.33%
Q4 201942.7K$4M+2.75%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tsfg, LLC’s full portfolio or all institutional holders of ABT.